BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20270314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20271107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260609T133000
DTEND;TZID=America/Chicago:20260609T183000
DTSTAMP:20260609T160611
CREATED:20260416T223534Z
LAST-MODIFIED:20260518T205659Z
UID:2693-1781011800-1781029800@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences RoundtableThe Next Phase: Capital Strategy & Regulatory Alignment
DESCRIPTION:Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the current administration\, emerging technologies\, the investment landscape\, and more. \n \nFeatured Panel Topics \nPipelines and Product Launches: The New Normal for Strategic FDA and Pricing Planning\nThis panel will explore regulatory issues impacting activities critical to successful product launches and exits today\, including regulatory approval\, disease awareness and other pre-approval communications\, reimbursement planning in the era of MFN policy considerations\, relationships with investigators\, and continued access for clinical trial patients following product approval but before formulary access. \n– Torrey Cope\, Partner\, Food\, Drug and Medical Device\n– Meena Datta\, Partner\, Global Co-leader\, Healthcare \nRegulated\, Risky\, or Revolutionary? AI’s Role Across Drug Discovery\, Devices\, and Wellness\nThis panel will discuss regulatory issues\, business plans\, and risk-mitigation strategies for investors and companies as they scale and commercialize AI tools.\n \n– Deeona Gaskin\, Partner\, Food\, Drug and Medical Device and Former Associate Chief Counsel for Enforcement\, FDA\n– Scott Kaplan\, Senior Vice President\, Quality\, Regulatory and Patient Safety\, Baxter\n– Michael Rohr\, Partner\, Emerging Companies and Venture Capital\n– Luis Vilarin\, Vice President\, Legal\, Flagship Pioneer \nLife Sciences Dealmaking in 2026: Where Capital and Collaboration Converge\nThis panel will discuss the evolving biotech transaction landscape\, from venture financings to strategic alliances. \n– Jason Kropp\, Partner\, Emerging Companies and Venture Capital\n– Irina Margine\, Sector Lead\, Biotech Private Investments\, Wellington Management\n– Rosemary Reilly\, Partner\, Emerging Companies and Venture Capital \nFIRESIDE CHAT\n“Navigating the New Environment in DC: New Advocacy Options for Life Sciences Companies at FDA and Beyond” \nA conversation with former Senior White House Official Trent Morse and Becky Wood\, co-leader of Sidley’s FDA Practice and former FDA Chief Counsel. \nAgenda\nRegistration:  1:30 p.m. ET\nProgram: 2:00 p.m. ET\nReception: 5:00 p.m. ET \nWho Should Attend?\nExecutives\, Investors\, General Counsel\, and Company Counsel \n\n\n\n\n\n\nBy invitation only. Space is limited. For more information\, contact bosevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-2026/
LOCATION:Boston\, MA
END:VEVENT
END:VCALENDAR